iPierian Harvard Case Solution & Analysis

IPierian case profiles run a biotechnology company, using the latest development of induced pluripotent stem cells (iPSCs), adult stem cells that have been reprogrammed "pluripotent" state, in which they can differentiate into nearly 200 different types of cells in the body. Science in this field is in its infancy, but the pace of change rapidly, as new discoveries are made and in companies developing applications for the technology. iPierian has established itself as a leader in the early space by creating a consistent way to create large volumes of high quality iPSCs and then differentiate these cells into neurons engine. The company must choose between three main areas, the tools of drug therapy, in which he can run the business and to continue to develop their technology. iPierian also have to take this decision in the context of the role of major players in the pharmaceutical industry, with which they can either partner or potentially compete in a race to find a successful application of iPSC technology. "Hide
by Robert Chess, Sarah Rosenthal Source: Stanford University, 26 pages. Publication Date: February 04, 2011. Prod. #: E393-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.